First Amendment to Amended and Restated 2002 Directors’ Stock Option Plan of Cubist Pharmaceuticals, Inc.

Contract Categories: Business Finance › Stock Agreements
Summary

This amendment updates the 2002 Directors’ Stock Option Plan for Cubist Pharmaceuticals, Inc. It prohibits directors from using promissory notes to pay for stock options and requires shareholder approval before any repricing of outstanding options can occur. The changes were approved by the company’s Board of Directors and are effective as of August 2, 2005.

Read More Arrow
EX-10.2 7 a05-14321_1ex10d2.htm EX-10.2

Exhibit 10.2

 

CUBIST PHARMACEUTICALS, INC.

 

FIRST AMENDMENT

TO

AMENDED AND RESTATED 2002 DIRECTORS’ STOCK OPTION PLAN

 

This FIRST AMENDMENT (this “Amendment”) to the Amended and Restated 2002 Directors’ Stock Option Plan (the “Plan”), of Cubist Pharmaceuticals, Inc., a Delaware corporation (the “Company”), is adopted by resolution of the Board of Directors of the Company (the “Board”) pursuant to a written consent in lieu of a meeting of the Board dated as of August 2, 2005 (the “Effective Date”).  Effective from and after the Effective Date, the Plan is hereby amended as follows:

 

1.                                       Section 8(c) of the Plan is hereby deleted and replaced in its entirety with the following:

 

“(c)    No Holder shall be permitted to effect payment of any amount of the Option Price of the Shares to be purchased by executing and delivering to the Company a promissory note.”

 

2.                                       The following sentence is hereby added to the end of Section 17 of the Plan:

 

“Notwithstanding the foregoing, no repricing of outstanding Options shall be permitted under the Plan without first receiving approval from the holders of Stock representing not less than a majority of the then outstanding Shares.”